Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bicarfen
2. Bicarphen
3. Bicarphene
4. Bicarphene Hydrochloride
5. Bikarfen
6. Quinuclidinyl-3-di(o-tolyl)carbinol
7. Quinuclidyl-3-di-o-tolylcarbinol
1. 57734-69-7
2. Sequifenadine [inn]
3. 1-azabicyclo[2.2.2]octan-3-yl-bis(2-methylphenyl)methanol
4. C7q3tbr3fp
5. Bicarphene
6. 1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]methanol Hydrochloride
7. Sequifenadina
8. Sequifenadinum
9. Sequifenadinum [latin]
10. Sequifenadina [spanish]
11. Unii-c7q3tbr3fp
12. Brn 1548429
13. Alpha,alpha-di-o-tolyl-3-quinuclidinemethanol
14. Benzhydrol, 2,2'-dimethyl-alpha-(3-quinuclidinyl)-
15. 1-azabicyclo[2.2.2]octane-3-methanol, Alpha,alpha-bis(2-methylphenyl)-, Hydrochloride
16. 3-quinuclidinemethanol, Alpha,alpha-di-o-tolyl-
17. Sequifenadine [mart.]
18. Sequifenadine [who-dd]
19. Schembl1813871
20. Chembl2105505
21. Schembl11761803
22. Dtxsid40866647
23. Albb-014236
24. Stl026230
25. Akos005174257
26. Db13566
27. Hy-w281862
28. Ncgc00326051-01
29. Cs-0326942
30. D10510
31. Ab01321356-02
32. Sr-01000944892
33. Q4418107
34. Sr-01000944892-1
35. 1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]methanol
36. (1-azabicyclo[2.2.2]octan-3-yl)bis(2-methylphenyl)methanol
| Molecular Weight | 321.5 g/mol |
|---|---|
| Molecular Formula | C22H27NO |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 321.209264485 g/mol |
| Monoisotopic Mass | 321.209264485 g/mol |
| Topological Polar Surface Area | 23.5 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 406 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
R - Respiratory system
R06 - Antihistamines for systemic use
R06A - Antihistamines for systemic use
R06AX - Other antihistamines for systemic use
R06AX32 - Sequifenadine
ABOUT THIS PAGE
A Sequifenadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sequifenadine, including repackagers and relabelers. The FDA regulates Sequifenadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sequifenadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sequifenadine supplier is an individual or a company that provides Sequifenadine active pharmaceutical ingredient (API) or Sequifenadine finished formulations upon request. The Sequifenadine suppliers may include Sequifenadine API manufacturers, exporters, distributors and traders.
Sequifenadine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sequifenadine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sequifenadine GMP manufacturer or Sequifenadine GMP API supplier for your needs.
A Sequifenadine CoA (Certificate of Analysis) is a formal document that attests to Sequifenadine's compliance with Sequifenadine specifications and serves as a tool for batch-level quality control.
Sequifenadine CoA mostly includes findings from lab analyses of a specific batch. For each Sequifenadine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sequifenadine may be tested according to a variety of international standards, such as European Pharmacopoeia (Sequifenadine EP), Sequifenadine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sequifenadine USP).
LOOKING FOR A SUPPLIER?
